allergenic extract
antigen laboratories, inc. - chaetomium globosum (unii: 5016wb8b8a) (chaetomium globosum - unii:5016wb8b8a) - chaetomium globosum 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.
allergenic extract
antigen laboratories, inc. - pea (unii: w4x7h8gyfm) (pea - unii:w4x7h8gyfm) - pea 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.
allergenic extract
antigen laboratories, inc. - salix lucida ssp. lasiandra pollen (unii: 9p9t267qmr) (salix lucida ssp. lasiandra pollen - unii:9p9t267qmr) - salix lucida ssp. lasiandra pollen 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.
standardized short ragweed pollen injection, solution
antigen laboratories, inc. - ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3) - ambrosia artemisiifolia pollen 100000 [au] in 1 ml - indications and usage allergenic extract is indicated for diagnostic testing and treatment (immunotherapy) of patients whose histories indicate allergic symptoms upon natural exposure to short ragweed pollen. confirmation is determined by skin testing. contraindications do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. recent myocardial infarction patients may not tolerate immunotherapy. children with nephrotic syndrome probably should not receive injections due to a possibility of immunization causing exacerbation of their nephrotic disease. standardized short ragweed extract is not intended for the treatment of patients who do not experience allergic symptoms upon natural exposure to the allergen. allergenic extracts are not intended for diagnosing patients whose skin does not manifest immediate hypersensitiv
standardized mite, dermatophagoides pteronyssinus injection, solution standardized mite, dermatophagoides farinae injection, so
antigen laboratories, inc. - dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k) - dermatophagoides pteronyssinus 10000 [au] in 1 ml - indications and usage standardized mite allergenic extract is indicated for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. an orderly approach to the diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. mite mixtures should not be used for diagnostic skin testing. the individual mites should be used. mite mixtures may be used for immunotherapy to treat patients who demonstrated sensitivity to both d. farinae and d. pteronyssinus mites. patients who react to both d. farinae and d. pteronyssinus have demonstrated a significant cross-reactivity. caution should be used in escalating treatment with mite mixtures.21 prick-puncture testing:
flaxseed injection, solution coffee injection, solution cottonseed injection, solution
antigen laboratories, inc. - flax seed (unii: 4110yt348c) (flax seed - unii:4110yt348c) - flax seed 0.05 g in 1 ml - for diagnostic use only. this product has not been shown by adequate data to be safe and effective for therapeutic use according to federal register notice dated november 16, 1994, vol. 59, no. 220. the following allergenic extracts are "for diagnostic use only": coffee (coffea arabic ), cottonseed (gossypium spp. ), flaxseed (linum usitatissimum ), leafhopper (cicadellidae), miller moth (night flying lepidoptera), cricket (gryllidae) and moth (frenatae). these extracts are intended for diagnostic testing of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying condition, possibly due to routine immunization. children with nephrotic syndrome should not receive injections due to immunization exacerbating nephrotic diseases. allergenic
allergenic extract
antigen laboratories, inc. - cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10) - cynodon dactylon pollen 10000 [bau] in 1 ml - indications and usage allergenic extract is indicated for diagnostic testing and treatment (immunotherapy) of patients whose histories indicate allergic symptoms upon natural exposure to grass allergens. confirmation is determined by skin testing. 10,000 bau/ml extracts are intended for percutaneous testing. if negative, 100,000 bau/ml products can be used for percutaneous test. dilutions made from 10,000 bau/ml products are indicated for immunotherapy of previously untreated patients. if 10,000 bau/ml product is tolerated and symptoms persist, dilutions made from 100,000 bau/ml can be administered. standardized grass pollen extracts labeled in bioequivalent allergy units (bau/ml) are not interchangeable with grass pollen extracts labeled in allergy units (au/ml) or with non-standardized grass pollen extracts. contraindications do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of underly
miller moth injection, solution
antigen laboratories, inc. - sitotroga cerealella (unii: 9t28i7bpno) (sitotroga cerealella - unii:9t28i7bpno) - sitotroga cerealella 0.05 g in 1 ml - for diagnostic use only. this product has not been shown by adequate data to be safe and effective for therapeutic use according to federal register notice dated november 16, 1994, vol. 59, no. 220. the following allergenic extracts are "for diagnostic use only": coffee (coffea arabic ), cottonseed (gossypium spp. ), flaxseed (linum usitatissimum ), leafhopper (cicadellidae), miller moth (night flying lepidoptera), cricket (gryllidae) and moth (frenatae). these extracts are intended for diagnostic testing of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying condition, possibly due to routine immunization. children with nephrotic syndrome should not receive injections due to immunization exacerbating nephrotic diseases. allergenic
cricket injection, solution
antigen laboratories, inc. - acheta domesticus (unii: p9s201x6lh) (acheta domesticus - unii:p9s201x6lh) - acheta domesticus 0.05 g in 1 ml - for diagnostic use only. this product has not been shown by adequate data to be safe and effective for therapeutic use according to federal register notice dated november 16, 1994, vol. 59, no. 220. the following allergenic extracts are "for diagnostic use only": coffee (coffea arabic ), cottonseed (gossypium spp. ), flaxseed (linum usitatissimum ), leafhopper (cicadellidae), miller moth (night flying lepidoptera), cricket (gryllidae) and moth (frenatae). these extracts are intended for diagnostic testing of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying condition, possibly due to routine immunization. children with nephrotic syndrome should not receive injections due to immunization exacerbating nephrotic diseases. allergenic
zanrit tablet
pharma dynamics (pty) ltd - tablet - 100,0 mg & 300,0 mg - each tablet contains ritonavir 100,0 mg atazanavir sulphate equivalent to atazanavir 300,0 mg